News
Article
Lonza Announces Agreement with Alexion
Author(s):
The addition of a new manufacturing line at Lonza’s Portsmouth, NH site enables Alexion to add dedicated product supply for 10 years.
Lonza Group announced on July 2 a long-term product supply agreement with Alexion under which Lonza will construct and launch a new suite dedicated to Alexion manufacturing at Lonza’s Portsmouth, NH site. Lonza reports the manufacturing line will be operational by the end of 2017
The agreement, and expansion of an existing manufacturing agreement, will supplement existing production of Alexion products at multiple Lonza facilities. Lonza will own and operate the suite at the Portsmouth site.
The expansion of the existing site will provide increased access to Lonza’s biological manufacturing and regulatory expertise, global workforce and customer service. Lonza has more than two decades of manufacturing experience with mammalian biotherapeutics.
Source: Lonza
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
